Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | GSK3B | P49841 | 2/20 | 0.54 |
| ▸ | PLAA | Q9Y263 | 3/20 | 0.53 |
| ▸ | ALPG | P10696 | 6/20 | 0.51 |
| ▸ | ALPL | P05186 | 2/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43409 | 1.00 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29389757 | 1.00 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| Boric Acid SCHEMBL10752697 | 0.94 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| Catechol SCHEMBL20361612 | 0.89 | GSK3B (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8080694 | 0.83 | GSK3B (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL21055987 | 0.83 | GSK3B (0.55) | KDM4EGSK3BTRPA1ALDH1A1MAPK1 | |
| SCHEMBL10352002 | 0.83 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8768769 | 0.83 | GSK3B (0.55) | CA1CA2KDM4EGSK3BTRPA1 | |
| SCHEMBL9908793 | 0.82 | GSK3B (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5455143 | 0.82 | KDM4E (0.49) | KDM4EGSK3BTRPA1ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140256989-A1 | PROCESS FOR THE PREPARATION OF HYDROXYTYROSOL | WACKER CHEMIE AG (DE) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256989-A1 | PROCESS FOR THE PREPARATION OF HYDROXYTYROSOL | HCAR3, HCAR1, HCAR2 | CA12 1721/4885CA1 695/4885CA2 286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.